Pilot Study of DFN-11 Injection in Medication Overuse Headache
NCT02583425 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2018-04-03
Summary
Efficacy and Safety Pilot Study of DFN-11 Injection in Medication Overuse Headache
Conditions
- Medication Overuse Headache
Interventions
- DRUG
-
DFN-11 Injection
Sponsors & Collaborators
-
Dr. Reddy's Laboratories Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-08-31
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
DFN-02 Open Label Safety Study in Patients With Acute Migraine
NCT02279082 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache
NCT02381795 ·Status: TERMINATED ·Phase: PHASE2
-
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
NCT02037425 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
NCT00250458 ·Status: COMPLETED ·Phase: PHASE3
-
Botox Injection in Treatment of Chronic Migraine
NCT02259075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
NCT01057160 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
NCT00055484 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
NCT03282838 ·Status: COMPLETED ·Phase: PHASE1
-
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
NCT01044251 ·Status: COMPLETED ·Phase: PHASE2
-
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839 ·Status: COMPLETED ·Phase: NA
-
A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
NCT00443352 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
NCT02485340 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED
-
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
NCT00660192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
"Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine
NCT03543254 ·Status: COMPLETED ·Phase: PHASE2
-
A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.
NCT04355845 ·Status: COMPLETED ·Phase: PHASE1
-
Can DFN-15 Terminate Migraine With Allodynia?
NCT03472378 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2951742 in Participants With Migraine
NCT01625988 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Detoxification Protocols for Treatment of Medication-overuse Headache
NCT02903329 ·Status: COMPLETED ·Phase: NA
-
Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT00432549 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity
NCT00203268 ·Status: COMPLETED ·Phase: NA
-
OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study
NCT01920945 ·Status: TERMINATED ·Phase: PHASE2
-
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
NCT00246337 ·Status: COMPLETED ·Phase: PHASE2
-
Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
NCT02932488 ·Status: TERMINATED ·Phase: PHASE1